蛋白酸酶2A-B56α复合体调节神经母细胞瘤中的N-Myc降解
Brian D Tran1, Irene Peris2, Ethan Wurman2
1Department of Pharmacology, University of Michigan, Ann Arbor, Michigan, USA; Rogel Cancer Center, University of Michigan, Ann Arbor, Michigan, USA.
The Journal of biological chemistry
|February 18, 2026
概括
研究人员发现,重新激活PP2A可以降低神经母细胞瘤中的N-Myc蛋白,通过向MYCN瘤信号来为高风险的神经母细胞瘤提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 高危神经母细胞瘤是一种致命的儿科癌症.
- MYCN放大驱动瘤的进展和治疗耐药性.
- 在神经母细胞瘤中,N-Myc 是一个具有挑战性的治疗点.
研究的目的:
- 研究PP2A-B56α在调节N-Myc蛋白稳定性的作用.
- 评估PP2A在神经母细胞瘤中重新激活的治疗潜力.
主要方法:
- 用针对PP2A的小分子DT-061.1.治疗神经母细胞瘤细胞系.
- 评估N-Myc蛋白水平,细胞活力和殖民地形成.
- 使用神经母细胞瘤异种移植模型进行体内研究.
主要成果:
- PP2A的重新激活显著降低了神经母细胞细胞中的N-Myc蛋白表达.
- DT-061治疗导致N-Myc蛋白质体的降解,并降低了细胞活力.
- 在DT-061治疗的异种移植模型中,瘤生长被抑制.
结论:
- PP2A-B56α调制有效地针对神经母细胞瘤中的MYCN瘤信号.
- 重新激活PP2A代表了高风险神经母细胞瘤的一个有前途的治疗策略.
相关概念视频
Abnormal Proliferation
5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Negative Regulator Molecules
38.6K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
38.6K
PI3K/mTOR/AKT Signaling Pathway
5.8K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.8K
Anaphase Promoting Complex
3.5K
The stepwise destruction of specific proteins is necessary for the progression and completion of the cell cycle. Such proteins are ubiquitinated by ubiquitin ligases and then subsequently destroyed by the proteasome. The SCF (Skp1/Cullin/F-box) and the anaphase-promoting complex (APC) are two important ubiquitin ligases involved in cell cycle progression. While SCF is active throughout the cell cycle, APC gets activated during metaphase to anaphase transition. Cdc20 or Cdh1 binds to APC and...
3.5K
mTOR Signaling and Cancer Progression
4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.9K
Protein Kinases and Phosphatases
15.3K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
15.3K


